Institute for Regenerative Medicine (Wake Forest Institute of Regenerative Medicine), Wake Forest School of Medicine Medical Center Boulevard, Winston-Salem, North Carolina, USA.
Department of Anesthesiology, Division of Molecular Medicine, UCLA David Geffen School of Medicine, Los Angeles, California, USA.
Am J Nephrol. 2017;46(5):380-389. doi: 10.1159/000482014. Epub 2017 Nov 7.
Renal protection is a critical concept for anesthesiologists, nephrologists, and urologists, since anesthesia and renal function are highly interconnected and can potentially interfere with one another. Therefore, a comprehensive understanding of anesthetic drugs and their effects on renal function remains fundamental to the success of renal surgeries, especially transplant procedures. Some experimental studies have shown that some anesthetics provide protection against renal ischemia/reperfusion (IR) injury, but there is limited clinical evidence.
The effects of anesthetic drugs on renal failure are particularly important in the context of kidney transplantation, since the conditions of preservation following removal profoundly influence the recovery of organ function. Currently, preservation procedures are typically based on the usage of a cold-storage solution. Some anesthetic drugs induce anti-inflammatory, anti-necrotic, and anti-apoptotic effects. A more thorough understanding of anesthetic effects on renal function can present a novel approach for developing organ-protective strategies. The aim of this review is to discuss the effects of different anesthetic drugs on renal function, with particular focus on IR injury. Many studies have demonstrated the organ-protective effects of some anesthetic drugs, specifically propofol, which indicate the potential of some anesthetics to introduce novel organ protective targets. This is not surprising, since lipid emulsions are major components of propofol, which accumulating data show provide organ protective effects against IR injury. Key Messages: Thorough understanding of the interaction between anesthetic drugs and renal function remains fundamental to the delivery of safe perioperative care and to optimizing outcomes after renal surgeries, particularly transplant procedures. Anesthetics can be repurposed for organ protection with more information about their effects, especially during transplant procedures. Here, we review the effects of different anesthetic drugs - specifically those that contain lipids in their structure, with special reference to IR injury.
对于麻醉师、肾病学家和泌尿科医生来说,肾脏保护是一个关键概念,因为麻醉和肾功能高度相关,并且可能相互干扰。因此,全面了解麻醉药物及其对肾功能的影响仍然是肾脏手术成功的基础,尤其是移植手术。一些实验研究表明,一些麻醉剂可以提供对肾缺血/再灌注(IR)损伤的保护作用,但临床证据有限。
在肾移植的背景下,麻醉药物对肾衰竭的影响尤为重要,因为在移除后,器官的保存条件对器官功能的恢复有很大影响。目前,保存程序通常基于冷存储溶液的使用。一些麻醉药物会诱导抗炎、抗坏死和抗凋亡作用。更深入地了解麻醉对肾功能的影响可以为开发器官保护策略提供新的方法。本综述的目的是讨论不同麻醉药物对肾功能的影响,特别是针对 IR 损伤。许多研究表明,一些麻醉药物,特别是异丙酚,具有器官保护作用,这表明一些麻醉剂有可能引入新的器官保护靶点。这并不奇怪,因为含有脂肪乳剂的异丙酚是其主要成分,越来越多的数据表明脂肪乳剂对 IR 损伤具有器官保护作用。
全面了解麻醉药物与肾功能之间的相互作用仍然是提供安全围手术期护理和优化肾脏手术后(特别是移植手术)结果的基础。随着对其作用的更多了解,可以将麻醉剂重新用于器官保护,尤其是在移植手术中。在这里,我们回顾了不同麻醉药物的作用 - 特别是那些结构中含有脂质的麻醉药物,特别提到了 IR 损伤。